Saxenda
(liraglutide)Novo Nordisk
Usage: SAXENDA is indicated for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with weight-related comorbidities, and in pediatric patients aged 12 and older with a body weight over 60 kg and obesity. It should not be combined with other liraglutide products.